1. Home
  2. LGI vs ASMB Comparison

LGI vs ASMB Comparison

Compare LGI & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGI
  • ASMB
  • Stock Information
  • Founded
  • LGI 2004
  • ASMB 2005
  • Country
  • LGI United States
  • ASMB United States
  • Employees
  • LGI N/A
  • ASMB N/A
  • Industry
  • LGI
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGI
  • ASMB Health Care
  • Exchange
  • LGI Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • LGI 210.5M
  • ASMB 198.6M
  • IPO Year
  • LGI N/A
  • ASMB 2010
  • Fundamental
  • Price
  • LGI $17.70
  • ASMB $23.82
  • Analyst Decision
  • LGI
  • ASMB Strong Buy
  • Analyst Count
  • LGI 0
  • ASMB 4
  • Target Price
  • LGI N/A
  • ASMB $38.67
  • AVG Volume (30 Days)
  • LGI 41.1K
  • ASMB 174.5K
  • Earning Date
  • LGI 01-01-0001
  • ASMB 11-06-2025
  • Dividend Yield
  • LGI 7.10%
  • ASMB N/A
  • EPS Growth
  • LGI N/A
  • ASMB N/A
  • EPS
  • LGI N/A
  • ASMB N/A
  • Revenue
  • LGI N/A
  • ASMB $33,247,000.00
  • Revenue This Year
  • LGI N/A
  • ASMB $12.44
  • Revenue Next Year
  • LGI N/A
  • ASMB N/A
  • P/E Ratio
  • LGI N/A
  • ASMB N/A
  • Revenue Growth
  • LGI N/A
  • ASMB 54.77
  • 52 Week Low
  • LGI $12.66
  • ASMB $7.75
  • 52 Week High
  • LGI $16.68
  • ASMB $27.17
  • Technical
  • Relative Strength Index (RSI)
  • LGI 64.56
  • ASMB 52.32
  • Support Level
  • LGI $17.52
  • ASMB $22.50
  • Resistance Level
  • LGI $17.78
  • ASMB $26.14
  • Average True Range (ATR)
  • LGI 0.17
  • ASMB 1.09
  • MACD
  • LGI -0.01
  • ASMB -0.52
  • Stochastic Oscillator
  • LGI 76.60
  • ASMB 28.16

About LGI Lazard Global Total Return and Income Fund

Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: